GLANCE: A double-blind, randomised, placebo-controlled, parallel-group safety study of natalizumab (Antegren) in combination with glatiramer acetate (Copaxone) in subjects with relapsing-remitting multiple sclerosis

被引：0

作者：

Goodman, A

Bar-Or, A

Miller, A

Miller, D

Panzara, M

Rossman, H

Schmierer, K

Toal, M

机构：

[1] Univ Rochester, Med Ctr, Rochester, NY 14627 USA

[2] Montreal Neurol Inst, Montreal, PQ, Canada

[3] Maimonides Hosp, Brooklyn, NY 11219 USA

[4] Inst Neurol, London WC1N 3BG, England

[5] Biogen Idec, Cambridge, MA USA

[6] Michigan Inst Neurol Disorders, Farmington Hills, MI USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：176 / 177

页数：2